"SEIZMET TRIO 0.3: Triple Action for Blood Sugar Control"

May 31, 2024

SEIZMET TRIO 0.3 

Glimepiride (2mg), Metformin SR (500mg), Voglibose (0.3mg)

Introduction

Glimepiride (2mg), Metformin SR (500mg), and Voglibose (0.3mg) is a potent combination medication designed to effectively manage type 2 diabetes. This triple-action therapy targets various aspects of glucose metabolism, helping to control blood sugar levels, improve insulin sensitivity, and slow down the absorption of carbohydrates.

Mechanism of Action

Glimepiride (2mg)

  • Glimepiride is a sulfonylurea that stimulates the pancreas to produce more insulin. The increased insulin levels help lower blood glucose by promoting the uptake of glucose into cells.

Metformin SR (500mg)

  • Metformin is a biguanide that reduces the amount of glucose produced by the liver. The sustained-release (SR) formulation ensures a steady release of the medication, providing prolonged glucose control. It also improves the body’s sensitivity to insulin, aiding in better glucose utilization.

Voglibose (0.3mg)

  • Voglibose is an alpha-glucosidase inhibitor that slows down the breakdown and absorption of carbohydrates in the intestines. This action helps to prevent spikes in blood sugar levels after meals.

Uses

  • Type 2 Diabetes Management: This combination is primarily used to manage type 2 diabetes in adults, helping to control blood sugar levels and prevent complications associated with diabetes.
  • Postprandial Glucose Control: Voglibose helps manage post-meal blood sugar spikes, providing more stable glucose levels throughout the day.

Dosage and Administration

The typical dosage is one tablet of Glimepiride (2mg), Metformin SR (500mg), and Voglibose (0.3mg) taken once daily, usually with the first main meal. Regular blood sugar monitoring and follow-ups with your healthcare provider are essential to ensure the medication’s effectiveness.

Side Effects

Common side effects include:

  • Nausea or upset stomach
  • Diarrhea
  • Dizziness
  • Hypoglycemia (low blood sugar)
  • Flatulence (gas)

Serious side effects may include:

  • Lactic acidosis (a rare but serious complication of metformin)
  • Severe hypoglycemia
  • Allergic reactions

Precautions

  • Kidney Function: Regular monitoring of kidney function is recommended, especially when using metformin.
  • Liver Function: Patients with liver disease should use this combination cautiously.
  • Heart Health: Use glimepiride cautiously in patients with cardiovascular conditions.

Conclusion

Glimepiride (2mg), Metformin SR (500mg), and Voglibose (0.3mg) offer a comprehensive approach to managing type 2 diabetes. By targeting different aspects of glucose metabolism, this combination helps maintain optimal blood sugar levels and improve overall health. Always follow your healthcare provider’s instructions and attend regular check-ups to ensure safe and effective treatment.Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

  For further information: 

 

 EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

 

   BUY NOW

 

 

 

SHARE WITH